PubMed Health⌕ Search

Biomedical subjects

R A Ross

Publications and source records attributed to R A Ross.

At least 73 records · Page 4Linked to original sources

Influence of substratum on the retrograde response of the rat superior cervical ganglion in vitro.

To study the role of the substratum on the retrograde response of injured peripheral noradrenergic neurons, embryonic rat superior cervical ganglia were grown in vitro on four different substrata: collagen, poly-D-lysine, fibronectin, or tissue culture plastic. The rate and pattern of neurite outgrowth were determined for a 2-week period following injury with explantation. In addition, changes in the activity of tyrosine hydroxylase, the neurotransmitter enzyme that has been shown to be altered during the retrograde response, was measured. The pattern and rate of neurite outgrowth varied directly with the ability of the neuronal growth cone to adhere to the underlying substratum. On poly-D-lysine and collagen, neurites grew as individual processes with extensive branching, whereas on plastic and fibronectin there was little branching and marked neurite fasciculation. The rate of neurite elongation on poly-D-lysine (0.75 mm/day) was faster than on collagen (.53 mm/day), fibronectin (0.33 mm/day), or plastic (0.15 mm/day). On plastic, neurons of the superior cervical ganglion showed a severe and prolonged retrograde response as characterized by a reversible decrease in tyrosine hydroxylase activity to 28% of control which persisted until the 10th day in culture. In contrast, on collagen, there was a smaller, but still significant, decrease in tyrosine hydroxylase activity to 73% of control which lasted only 5 to 6 days. On poly-D-lysine, there was no measureable change in the activity of that enzyme after injury. These studies provide quantitative evidence showing an important role of the microenvironment, and in particular the extracellular matrix, in determining the ability of neurons to respond successfully to injury.

Adrenergic Fibers↗

Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system.

We have found highly predictable patterns of protooncogene expression in cell lines and tumor tissue of neuroblastoma (NB), a tumor of the peripheral nervous system (PNS). These patterns make it possible to recognize two different genetically definable subgroups among histopathologically indistinguishable tumors. Additionally, we have identified a difference in neurotransmitter biosynthetic enzyme activity in these two subgroups of NB. The patterns of protooncogene expression and neurotransmitter biosynthetic enzymes suggests that these tumors arise in different cells of the PNS.

Cell Line↗

Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins.

Differentiation of human neuroblastoma (NB) was studied in vitro with five NB cell lines treated with dibutyryl cyclic adenosinemonophosphate and retinoic acid. Although the above agents induced different responses in the various cell lines, three overall morphologic phenotypes emerged: a neuronal, characterized by cell processes and neurosecretory granules, a flat cell without pigment, which displayed basal lamina pertinent to Schwann cells, and a flat pigmented cell which exhibited melanosomes, similarly to melanocytes. The activity of the Schwann cell enzyme cyclic nucleotidyl phosphohydrolase increased considerably in one condition, after induction of a predominantly flat cell phenotype. All studied NB cell lines were capable of synthesizing and expressing the extracellular matrix proteins laminin (LM), fibronectin (FN), and Type IV collagen; but a specific pattern of expression emerged after differentiation, which was proportional to normal tissue equivalents: neuronal--none; melanocytic--FN only; and Schwann cell--large amounts of FN, LM, and Type IV collagen.

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase↗

Characterization of human neuroblastoma cell lines established before and after therapy.

Six new cell lines have been established from human neuroblastomas. Cell line SMS-KAN, from primary tumor before therapy, and line SMS-KANR, from bone marrow after chemotherapy and radiotherapy, were established from the same patient. Cell lines SMS-KCN (from primary tumor before any therapy) and SMS-KCNR (from bone marrow after chemotherapy) were established from another patient. Two other lines (SMS-MSN and SMS-SAN) were established from different patients before any therapy was given. Cell lines established from recurrent disease after chemotherapy (SMS-KANR and SMS-KCNR) had significantly shorter doubling times and increased plating efficiencies compared to those of cell lines derived from the same patient before chemotherapy (SMS-KAN and SMS-KCN). All cell lines contained tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and dopamine-beta-hydroxylase. Measurable amounts of choline acetyltransferase were also detected in SMS-KAN and SMS-KANR. Karyotype analysis showed all cell lines except SMS-MSN to be pseudodiploid with modal numbers of 46 and deletions of the short arm of chromosome 1; SMS-MSN had a modal number of 57-58 chromosomes. All cell lines had double-minute chromosomes, except SMS-KANR, which had abnormally banding regions. These new cell lines provide in vitro models of neuroblastoma suitable for the study of differences in neuroblastoma cell populations before chemotherapy as compared to the cell populations that proliferate after therapy.

Catecholamines↗

Differential drug sensitivity of human neuroblastoma cells.

A 6-day in vitro growth-inhibition assay was used to determine relative sensitivity of six human neuroblastoma cell lines to three classes of cancer chemotherapeutic agents: antimetabolites (methotrexate, methasquin, and cytarabine); antimitotics (vincristine, vinblastine, vindesine, colchicine, and demecolcine); and antibiotics (dactinomycin and doxorubicin). Human fibroblast lines served as a reference standard. Whereas response to antimetabolites by four of five neuroblastoma lines tested was similar to that of fibroblasts, SK-N-MC cells were significantly more sensitive (fivefold to 16-fold) to the three drugs. Human neuroblastoma cell lines were also differentially sensitive to antimitotics, especially to vincristine. In particular, SK-N-MC, IMR-32, and LA-N-2 cells were threefold to 17-fold more sensitive to this drug than were the SK-N-SH and SK-N-BE(2) lines. With the exception of SK-N-SH, all of the human neuroblastoma lines were considerably more sensitive to vincristine than were human fibroblasts. The same three highly vincristine-responsive lines were also significantly more sensitive to the other alkaloidal drugs as compared to fibroblasts. However, human neuroblastoma and fibroblastic cells responded similarly to the two antibiotics. The only cellular attribute consistently correlated with greater sensitivity to the antimitotics among the six cell lines tested was expression of the neurotransmitter biosynthetic enzyme choline acetyltransferase. A differential response to the vinca alkaloids was also exhibited by clonal sublines of SK-N-SH. One subpopulation (SH-EP) expressing a nonneuronal, substrate-adherent, variant phenotype was at least fourfold to eightfold more drug sensitive than its neuroblastic counterpart (SH-SY5Y) or the parental SK-N-SH population. In addition to confirming reports of clinical efficacy of the various classes of agents, these data have demonstrated a variation in response possibly related to type or degree of neuronal differentiation and emphasize the importance of understanding the phenotypic diversity commonly observed in neuroblastoma.

Antibiotics, Antineoplastic↗

Inverse temporal relationship between rate of neurite outgrowth and neurotransmitter function in rat superior cervical ganglion in vitro.

Explanation of the embryonic rat superior cervical ganglion initiated a retrograde response in noradrenergic neurons. By the 4th day of explanation, tyrosine hydroxylase activity per cell decreased to 62% of the day 0 control value. The rate of neurite outgrowth during the same period increased by 66%. By the 6th day both tyrosine hydroxylase activity and rate of neurite outgrowth returned to initial values. This inverse relationship is consistent with a proposed reordering of synthetic priorities that occurs in the parental cell body during axonal regeneration.

Adrenergic Fibers↗

Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro.

The human neuroblastoma cell line SK-N-SH comprises cells that undergo morphological and biochemical interconversion between a primitive sympathoblast and a variant, epithelial-like cell type which does not express the neuronal characteristics of the SK-N-SH cell line. Since neural crest cells, from which neuroblastomas are presumed to arise, can undergo transdifferentiation in culture from a neuronal phenotype into other cellular phenotypes, particularly into neurilemmal cells and melanocytes, the present study was undertaken to determine whether this capacity is preserved in malignant cells of the peripheral nervous system. Activities for tyrosinase, a melanocyte marker enzyme, and 2':3'-cyclic nucleotide phosphohydrolase, a Schwann-cell marker enzyme, were measured in clones of the two cell types. While no significant differences in 2':3'-cyclic nucleotide phosphohydrolase activity were measurable, tyrosinase activity was detectable only in the flattened neuroblastoma variant cell lines and was comparable to that in some human melanoma cell lines. The tyrosinase activity in neuroblastoma cell variants increased with cell density and was significantly elevated by melanocyte-stimulating hormone and 8-bromo-cyclic adenosine monophosphate, similar to that seen in melanoma cells in culture. Thus, our findings show that human neuroblastoma cells can undergo bidirectional transdifferentiation in vitro between a neuronal and a melanocyte phenotype, possibly reflecting a process which occurs in the patient.

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase↗

Coordinate morphological and biochemical interconversion of human neuroblastoma cells.

This study was undertaken to determine whether the two type of cells (one neuroblast-like and the other epithelial in appearance) of the human neuroblastoma line SK-N-SH in culture undergo morphological interconversion, whether conversion is bidirectional, and whether there are coordinate neurochemical changes. Phenotypic analysis of serially isolated neuroblast clones (SH-SY, SH-SY5, SH-SY5Y) revealed conversion to epithelial-like cells. Conversely, conversion also was promoted from an epithelial-like clone (SH-EP) to neuroblastic subclones. Cell origin could be verified because of a marker chromosome specific to SH-EP. Only neuroblastic subclones of SH-EP contained activities for tyrosine hydroxylase and dopamine-beta-hydroxylase, enzymes unique to catecholamine neurons; epithelial-like cells lacked activities for these enzymes. These findings indicate a coordinate morphological and biochemical interconversion of neuroblastoma SK-N-SH cells and reveal a plasticity in phenotypic expression in malignant neuronal cells.

Cell Line↗

Adolescent drug use and other behaviors.

Little systematic information is available concerning the association between adolescent drug usage and other forms of behavior. The present study addressed this issue. Two hundred and thirty-one adolescents completed questionnaires concerning their use of drugs (alcohol, tobacco, pain-killers, marijuana, etc.). Factor analysis of endorsements of a broad range of behaviors, followed by regression analysis, indicated that sexual behavior, general delinquency, school misbehavior, social behavior and studying/reading (--) were all related to drug use. School achievement (--) and domestic behavior (--) gave lower correlations. Religious behavior did not emerge as a clear correlate.

Adolescent↗

Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines.

Fourteen human neuroblastoma cell lines were studied for expression and regulation of neurotransmitter-synthesizing enzymes. All cell lines contained activities of adrenergic and/or cholinergic neurons and 13 expressed activities for both. None contained enzymes for serotonergic or GABAergic neurons. Enzyme activity was characteristic for a given cell line. Enzyme activity in cell lines was sensitive to growth phase, culture medium, and concentration of fetal bovine serum.

Aromatic-L-Amino-Acid Decarboxylases↗

Differences in utero in activities of catecholamine biosynthetic enzymes in adrenals of spontaneously hypertensive rats.

1. We sought to determine if catecholamine biosynthetic enzymes of spontaneously hypertensive rats (SHR) differed from those of normotensive Wistar--Kyoto (WKY) and Sprague--Dawley (SD) control rats before birth. 2. By immunocytochemical and biochemical methods we compared strains for the time of appearance and maturation of the enzymes tyrosine hydroxylase (TH), dopamine-beta-hydroxylase (DBH) and phenylethanolamine-N-methyltransferase (PNMT) in sympathetic ganglia and adrenals. 3. The time of appearance of enzymes was identical in all three strains: TH and DBH first appeared in sympathetic ganglia on embryonic day 11 (E11) and in adrenal medulla on E16. PNMT, restricted to adrenal medulla, appeared later on E18. 4. The activity of adrenal TH prenatally on E18 and E21 and at day of birth (P1) in SHR was approximately two fold that in WKY or SD rats. In contrast PNMT was lower in SHR but only on E18. 5. Thus, although the timing of the first expression of adrenergic phenotypes is similar in SHR and normotensive controls, the differences in TH activity in adrenals suggest an enhanced biosynthetic capacity for catecholamines in this strain before birth. 6. We conclude that SHR differ from normotensive rats from the first expression of some of the genes controlling catecholamine biosynthesis.

Adrenal Glands↗

Postoperative pain prevention by continuous epidural infusion. A study of the clinical effects and the plasma concentrations obtained.

A method for postoperative pain prevention is described using epidural bupivacaine infused by means of a variable rate peristaltic pump. High plasma concentrations of bupivacaine were found but no serious signs of bupivacaine toxicity were observed and the method proved satisfactory in practice. Theoretical and practical considerations and aspects of clinical management are discussed.

Aged↗